Skip to main content

Day: January 13, 2022

POAI Reports Strong Results From Its AI Cancer Drug Evaluation  

MINNEAPOLIS, Jan. 13, 2022 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI) reported the preliminary results of its Discovery 2021 program today, announcing that its Helomics subsidiary’s evaluation demonstrated their proprietary Artificial Intelligence (AI) program CoRE™ (Computational Research Engine), combined with their tumor profile data and matched ovarian cancer samples, could identify potential new chemotherapy drug uses. These drugs are not currently approved for ovarian cancer, but, with further study, could be used for ovarian cancer treatment following clinical trial and regulatory approval. The Discovery 2021 program has combined Helomics’ proprietary knowledgebase, its AI Machine Learning Program and its TruTumor™ platform to create PeDAL™ (Patient-centric Discovery by Active Learning). PeDAL is a unique...

Continue reading

ReShape Lifesciences Strengthens Leadership Team with Appointment of Michael Bordainick as Senior Vice President, Commercial Operations

Seasoned Executive Brings Significant Operational and Commercial Experience to Accelerate the Company’s Growth SAN CLEMENTE, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) — ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the appointment of Michael Bordainick as its Senior Vice President, Commercial Operations. In this newly created role, as part of the Company’s next phase of operational growth, Mr. Bordainick will be responsible for strengthening the strategic development and executional efficiencies of the sales and marketing teams. “As Michael brings significant experience and capabilities to advance ReShape’s recently launched commercial programs, including direct-to-consumer marketing and enhanced support for our clinical customers, he will be...

Continue reading

Skyharbour’s Partner Company Azincourt Energy Provides Update on Camp Construction and Drill Mobilization at East Preston Uranium Project, Saskatchewan

Vancouver, BC, Jan. 13, 2022 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd.’s (TSX-V:SYH) (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”) partner company Azincourt Energy (“Azincourt”) is pleased to announce that construction of the exploration camp for the winter 2022 exploration program is underway at the East Preston uranium project, located in the western Athabasca Basin, Saskatchewan, Canada. Project Location – Western Athabasca Basin, Saskatchewan, Canada:https://www.skyharbourltd.com/_resources/maps/Sky_EastPreston_20211209.jpg Discovery Mining Services is building the exploration camp at Snoop Lake and will maintain, staff, and manage the camp for the duration of the program, under the supervision of TerraLogic Exploration Inc. In addition, drilling and geological crews will be arriving on-site in the next few days, and drilling...

Continue reading

Mullen Automotive Electric Vehicle Program Update

Mullen updates shareholders on key efforts for Mullen FIVE and Mullen EV Cargo Van Programs BREA, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, announces today an update for Mullen Shareholders on the Mullen FIVE EV Crossover Program and the Mullen EV Cargo Van Program. “I am excited to share updates about our vehicle programs for our valued shareholders.  The Mullen team has been working diligently on key initiatives both here in Southern California and outside Tunica, Mississippi, at our AMEC manufacturing facility for both our FIVE EV Crossover and EV Cargo Van programs,” said David Michery, CEO and chairman of Mullen Automotive. Mullen FIVE Program The Mullen engineering team, along with...

Continue reading

Muscle Maker, Inc. Adds Franchise Sales and Training Team To Support Expansion Plans

Brand adds two franchise sales leaders and corporate trainer to strengthen infrastructure LEAGUE CITY, TEX., Jan. 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Muscle Maker, Inc. (Nasdaq: GRIL), the parent Company of Pokemoto, Superfit Foods and Muscle Maker Grill restaurants, today announced the addition of three new team members to support Pokemoto’s growth strategy: Mike Spavelko, Vice President of Franchise Sales; Kimberly Tauch, Franchise Sales and Development Manager and Jennifer Holden, Director of Corporate and Franchise Training.  The new team members will support franchising expansion plans and training efforts for Pokemoto, which recently announced the signing of 25 new franchise agreements. Pokemoto is ramping up its resources and infrastructure to support its growth strategy by bringing on new team members...

Continue reading

vTv Therapeutics Shares Updated Corporate Presentation

HIGH POINT, N.C., Jan. 13, 2022 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company committed to improving the quality of life for people with diabetes, is sharing its updated corporate presentation highlighting its lead program TTP399, a novel oral liver-selective glucokinase activator, as a transformative treatment in the reduction of hypoglycemic episodes for the global diabetes population. Key Takeaways include:Hypoglycemia is common in people with type 1 diabetes and can occur quickly, with symptoms including sweating, nausea, coordination problems, headaches and even seizures. TTP399 may be used as a once-daily, oral adjunctive therapy in a $16B global insulin market for the reduction of hypoglycemic episodes. TTP399 has been tested in almost 600 patients to date with no evidence...

Continue reading

Brooklyn ImmunoTherapeutics Provides Update on Regenerative Medicine Intellectual Property Portfolio

NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) — Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today announces that 18 new patents were issued and 17 new patent applications were filed in 2021. The intellectual property is owned by Factor Bioscience (“Factor”) and exclusively licensed to Brooklyn for various fields of therapeutic use. The newly-issued patents encompass those covering the Company’s mRNA-based cellular reprogramming and gene editing technology, as well as nucleic acid delivery using Brooklyn’s ToRNAdo™ lipid nanoparticle technology (LNP). “We believe that the newly issued patents reflect the exceptional and innovative...

Continue reading

Grayscale Investments® Updates Pricing Methodology for Grayscale® Zcash Trust, Grayscale® Stellar Lumens Trust, and Grayscale® Horizen Trust

New York, Jan. 13, 2022 (GLOBE NEWSWIRE) — Grayscale Investments®, the sponsor (the “Sponsor”) of Grayscale® Zcash Trust (OTCQX: ZCSH), Grayscale® Stellar Lumens Trust (OTCQX: GXLM), and Grayscale® Horizen Trust (OTCQX: HZEN) (the “Trusts”) has updated the methodology used to determine the price of the Digital Assets underlying each of the Trusts.  Grayscale is issuing this release in accordance with the disclosure obligations of OTCQX®. The Trusts’ Quarterly Report and other disclosures, published to satisfy the Alternative Reporting Standard disclosure guidelines for OTCQX, are available at Grayscale® Zcash Trust, Grayscale® Stellar Lumens Trust, and Grayscale® Horizen Trust. Grayscale Zcash Trust and Grayscale Stellar Lumens Trust each values its Digital Assets for operational purposes by reference to the volume-weighted...

Continue reading

Year in Review and Looking to 2022

SAN JOSE, CA, Jan. 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Sonasoft Corp. (OTCQB: SSFT), creators of the innovative Sonasoft AI Bot Runtime Engine, SAIBRE, closed out 2021 in a strong position. Highlights include tremendous progress in developing SAIBRE, a new strategic partnership, and a renewed focus on end-to-end AI projects. Taken together, this ensures that companies who engage Sonasoft will achieve a successful AI transformation, from data exploration and data science, through to delivery of a productionized AI solution. Sonasoft finds itself in a great position for 2022, ready to deliver new OEM partnerships that will help other companies overcome the challenging conditions created by COVID. SAIBRE Platform 2021 saw the announcement of SAIBRE, Sonasoft’s newly developed AI engine. SAIBRE cements Sonasoft’s position...

Continue reading

Harbor Custom Development, Inc. to Present at the Sidoti & Company Virtual Small Cap Conference Live Via Webcast

Gig Harbor, Washington , Jan. 13, 2022 (GLOBE NEWSWIRE) — Harbor Custom Development, Inc. (Nasdaq: HCDI, HCDIP, HCDIW, HCDIZ) (“Harbor,” “Harbor Custom Homes®,” or the “Company”), an innovative and market leading real estate company involved in all aspects of the land development cycle, will present virtually to the investment community via webcast at the Sidoti & Company Virtual Small Cap Conference on Thursday, January 20, 2022, at 12:15 p.m. (EDT). The live broadcast of the presentation may be accessed under the events and presentations section of Harbor Custom Development’s investor website at https://investors.harborcustomhomes.com. Participants are encouraged to log on at least five minutes prior to the start of the presentation. About Harbor Custom Development, Inc. Harbor Custom Development, Inc. is a real estate...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.